Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $45.57 million. The enterprise value is -$82.90 million.

Market Cap	45.57M
Enterprise Value	-82.90M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

XLO has 5.78 million shares outstanding. The number of shares has increased by 18.53% in one year.

Current Share Class	5.78M
Shares Outstanding	5.78M
Shares Change (YoY)	+18.53%
Shares Change (QoQ)	+22.38%
Owned by Insiders (%)	9.30%
Owned by Institutions (%)	22.75%
Float	3.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.09
Forward PS	1.73
PB Ratio	1.05
P/TBV Ratio	1.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.20.

Current Ratio	2.58
Quick Ratio	2.53
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.53% and return on invested capital (ROIC) is -77.21%.

Return on Equity (ROE)	-132.53%
Return on Assets (ROA)	-23.24%
Return on Invested Capital (ROIC)	-77.21%
Return on Capital Employed (ROCE)	-42.66%
Weighted Average Cost of Capital (WACC)	3.13%
Revenue Per Employee	$575,868
Profits Per Employee	-$461,000
Employee Count	76
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.06% in the last 52 weeks. The beta is -0.12, so XLO's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-32.06%
50-Day Moving Average	8.03
200-Day Moving Average	9.47
Relative Strength Index (RSI)	40.40
Average Volume (20 Days)	33,643

Short Selling Information

The latest short interest is 174,319, so 3.01% of the outstanding shares have been sold short.

Short Interest	174,319
Short Previous Month	182,492
Short % of Shares Out	3.01%
Short % of Float	5.06%
Short Ratio (days to cover)	3.82

Income Statement

In the last 12 months, XLO had revenue of $43.77 million and -$35.04 million in losses. Loss per share was -$7.73.

Revenue	43.77M
Gross Profit	43.77M
Operating Income	-41.98M
Pretax Income	-35.04M
Net Income	-35.04M
EBITDA	-40.44M
EBIT	-41.98M
Loss Per Share	-$7.73

Full Income Statement

Balance Sheet

The company has $137.53 million in cash and $6.95 million in debt, giving a net cash position of $130.58 million or $22.58 per share.

Cash & Cash Equivalents	137.53M
Total Debt	6.95M
Net Cash	130.58M
Net Cash Per Share	$22.58
Equity (Book Value)	35.27M
Book Value Per Share	7.79
Working Capital	88.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.99 million and capital expenditures -$518,000, giving a free cash flow of -$5.51 million.

Operating Cash Flow	-4.99M
Capital Expenditures	-518,000
Depreciation & Amortization	1.54M
Net Borrowing	n/a
Free Cash Flow	-5.51M
FCF Per Share	-$0.95

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -95.92% and -80.05%.

Gross Margin	100.00%
Operating Margin	-95.92%
Pretax Margin	-80.05%
Profit Margin	-80.05%
EBITDA Margin	-92.40%
EBIT Margin	-95.92%
FCF Margin	n/a

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.53%
Shareholder Yield	-18.53%
Earnings Yield	-73.49%
FCF Yield	-11.56%

Analyst Forecast

The average price target for XLO is $28.00, which is 255.33% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	255.33%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	-12.57%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 16, 2026. It was a reverse split with a ratio of 1:14.

Last Split Date	Mar 16, 2026
Split Type	Reverse
Split Ratio	1:14

Scores

XLO has an Altman Z-Score of -3.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.52
Piotroski F-Score	3